Enasidenib,Azacitidine
Servier
['transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'myeloid', '2019', '2018', 'beataml', 'mds', 'novo ']
#ash22 session 636 on mds keeps going with delving into identification of novel targets for cmml-bp! bravissimo!!! 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own